
Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented the CAGR of over 15%, hitting RMB13.3 billion with the year-on-year growth rate of 16.7% in 2012. Moreover, the market will accelerate its pace in the wake of China’s medical reform, enhanced health awareness of people and improved physical examination technology. In China, in vitro diagnostic reagents consist of biochemical diagnostic reagents, immune diagnostic reagents, molecular diagnostic reagents and hematology diagnostic reagents. Biochemical and immune diagnostic reagents enjoyed the highest 70% market share together in 2012, which was determined by the domestic medical demand. Chinese economy and the government medical expenditure stay at a low level, which affects the medical diagnosis consumption seriously.